A Longitudinal Mixed-Methods Examination of Positive Health Check: Implementation Results From a Type 1 Effectiveness-Implementation Hybrid Trial

被引:6
作者
Garner, Bryan R. [1 ]
Burrus, Olivia [1 ]
Ortiz, Alexa [1 ]
Tueller, Stephen J. [1 ]
Peinado, Susana [1 ]
Hedrick, Haley [1 ]
Harshbarger, Camilla [2 ]
Galindo, Carla [2 ]
Courtenay-Quirk, Cari [2 ]
Lewis, Megan A. [1 ]
机构
[1] RTI Int, Res Triangle Pk, NC USA
[2] Ctr Dis Control & Prevent, Div HIV Prevent, Atlanta, GA USA
关键词
HIV; implementation effectiveness; web-based interventions; computer-based interventions; video interventions; medication adherence; ANTIRETROVIRAL THERAPY; IMPROVE ADHERENCE; HIV PREVENTION; INTERVENTION; SCIENCE; ACCEPTABILITY; PERSPECTIVES; DETERMINANTS; FRAMEWORK; PROGRAM;
D O I
10.1097/QAI.0000000000003018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Positive Health Check is an evidence-based video doctor intervention developed for improving the medication adherence, retention in care, and viral load suppression of people with HIV receiving clinical care. Setting: Four HIV primary care clinics within the United States. Methods: As part of a type 1 hybrid trial, a mixed-methods approach was used to longitudinally assess the following 3 key implementation constructs over a 23-month period: innovation-values fit (ie, the extent to which staff perceive innovation use will foster the fulfillment of their values), organizational readiness for change (ie, the extent to which organizational members are psychologically and behaviorally prepared to implement organizational change), and implementation climate (ie, the extent to which implementation is expected, supported, and rewarded). Quantitative mixed-effects regression analyses were conducted to assess changes over time in these constructs. Qualitative analyses were integrated to help provide validation and understanding. Results: Innovation-values fit and organizational readiness for change were found to be high and relatively stable. However, significant curvilinear change over time was found for implementation climate. Based on the qualitative data, implementation climate declined toward the end of implementation because of decreased engagement from clinic champions and differences in priorities between research and clinic staff. Conclusions: The Positive Health Check intervention was found to fit within HIV primary care service settings, but there were some logistical challenges that needed to be addressed. Additionally, even within the context of an effectiveness trial, significant and nonlinear change in implementation climate should be expected over time.
引用
收藏
页码:47 / 57
页数:11
相关论文
共 50 条
  • [31] Addressing adverse social determinants of health in pediatric primary care: Study protocol for a hybrid type 2 effectiveness-implementation randomized controlled trial in two national pediatric practice-based research networks
    Brochier, Annelise
    Torres, Alessandra
    Tyrrell, Hollyce
    Paz, Katherine Barahona
    Wexler, Mikayla Gordon
    Griffith, Miranda
    Joiner, Terence
    Magardino, Angela
    Messmer, Emily
    Rogers, Stephen
    Scheindlin, Benjamin
    Serwint, Janet R.
    Sharif, Iman
    Shone, Laura P.
    Stockwell, Melissa S.
    Tripodis, Yorghos
    Garg, Arvin
    Drainoni, Mari- Lynn
    CONTEMPORARY CLINICAL TRIALS, 2024, 138
  • [32] Evaluating the delivery of Problem Management Plus in primary care settings in rural Rwanda: a study protocol using a pragmatic randomised hybrid type 1 effectiveness-implementation design
    Smith, Stephanie L.
    Nyirandagijimana, Beatha
    Hakizimana, Janvier
    Levy, Roger P.
    Bienvenu, Robert
    Uwamwezi, Anathalie
    Hakizimfura, Octavien
    Uwimana, Eugenie
    Kundu, Priya
    Mpanumusingo, Egide
    Nshimyiryo, Alphonse
    Rusangwa, Christian
    Kateera, Fredrick
    Mukasakindi, Hildegarde
    Raviola, Giuseppe
    BMJ OPEN, 2021, 11 (12):
  • [33] ENABLE-SG (Educate, Nurture, Advise, Before Life Ends for Singapore) as a proactive palliative care model: protocol for a hybrid type 1 effectiveness-implementation randomized wait-list controlled trial
    Ke, Yu
    Cheung, Yin Bun
    Bakitas, Marie
    Odom, J. Nicholas
    Lum, Elaine
    Tan, Daniel Shao Weng
    Tan, Tira J.
    Finkelstein, Eric
    Oh, Hong Choon
    Zhou, Siqin
    Yang, Grace Meijuan
    BMC PALLIATIVE CARE, 2024, 23 (01) : 29
  • [34] Addressing cost barriers to healthy eating with Eat Well, a prescription produce subsidy, for patients with diabetes and at risk for food insecurity: Study protocol for a type 1 hybrid effectiveness-implementation pragmatic randomized controlled trial
    Drake, Connor
    Granados, Isa
    Rader, Abigail
    Brucker, Amanda
    Hoeffler, Sam
    Goldstein, Benjamin A.
    Chamorro, Ceci
    Johnson, Fred
    Hinz, Eugenia McPeek
    Bedoya, Armando D.
    German, Jashalynn C.
    Hauser, Jillian
    Thacker, Connie
    Spratt, Susan E.
    CONTEMPORARY CLINICAL TRIALS, 2024, 145
  • [35] Transitional Care Support for Medicaid-Insured Patients With Serious Mental Illness: Protocol for a Type I Hybrid Effectiveness-Implementation Stepped-Wedge Cluster Randomized Controlled Trial
    Carthon, J. Margo Brooks
    Brom, Heather
    Amenyedor, Kelvin Eyram
    Harhay, Michael
    Grantham-Murillo, Marsha
    Nikpour, Jacqueline
    Lasater, Karen B.
    Golinelli, Daniela
    Cacchione, Pamela Z.
    Bettencourt, Amanda P.
    JMIR RESEARCH PROTOCOLS, 2024, 13
  • [36] Supporting Unhealthy Substance use care Through a whole person Approach and user centered INtegration into primary care (SUSTAIN): Study protocol for a type 2 hybrid effectiveness-implementation trial
    Simon, Claire B.
    Britz, Jacqueline B.
    Keiser, Brennan
    Brooks, E. Marshall
    Krist, Alex H.
    Franko, Nicholas
    Webel, Benjamin
    Hatch, Mary A.
    Tsui, Judith I.
    Stephens, Kari A.
    Tong, Sebastian T.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2025, 171
  • [37] Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness study
    Garris, Cindy P.
    Czarnogorski, Maggie
    Dalessandro, Marybeth
    D'Amico, Ronald
    Nwafor, Toyin
    Williams, Will
    Merrill, Deanna
    Wang, YuanYuan
    Stassek, Larissa
    Wohlfeiler, Michael B.
    Sinclair, Gary, I
    Mena, Leandro A.
    Thedinger, Blair
    Flamm, Jason A.
    Benson, Paul
    Spreen, William R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 (09)
  • [38] Pre-Exposure Prophylaxis Integration Into Family Planning Services at Title X Clinics in the Southeastern United States: Protocol for a Mixed Methods Hybrid Type I Effectiveness Implementation Study (Phase 2 ATN 155)
    Sheth, Anandi N.
    Hussen, Sophia A.
    Escoffery, Cam
    Haddad, Lisa B.
    Powell, Leah
    Brown, Nakita
    Filipowicz, Teresa R.
    McCumber, Micah
    Sanchez, Maria
    Renshaw, Laura
    Psioda, Matthew A.
    Sales, Jessica M.
    JMIR RESEARCH PROTOCOLS, 2020, 9 (09):
  • [39] Protocol for a type 2 hybrid effectiveness-implementation study expanding, implementing and evaluating electronic health record- integrated patient-reported symptom monitoring in a multisite cancer centre
    Garcia, Sofia F.
    Smith, Justin D.
    Kallen, Michael
    Webster, Kimberly A.
    Lyleroehr, Madison
    Kircher, Sheetal
    Bass, Michael
    Cella, David
    Penedo, Frank J.
    BMJ OPEN, 2022, 12 (05):
  • [40] Improving HIV testing, linkage, and retention in care among South African men through U = U messaging: A study protocol for two sequential hybrid type 1 effectiveness-implementation randomized controlled trials
    Medina-Marino, Andrew
    Sibanda, Nkosiyapha
    Putt, Mary
    Joseph Davey, Dvora
    Smith, Phillip
    Thirumurthy, Harsha
    Bekker, Linda-Gail
    Buttenheim, Alison
    PLOS ONE, 2024, 19 (11):